Dbv Technologies S A 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Dbv Technologies S A 's ROA in the second quarter of 2026?
Dbv Technologies S A recorded a cumulative net loss of $-176 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -78.8%.

However, within the Healthcare sector 687 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4177, from total ROA ranking in the first quarter of 2026 at 4948.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	32.22 %	462.11 %	-39.03 %	97.97 %	175.13 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-176	-167	-147	-125	-122
Return On Assets (TTM)	-78.8 %	-79.84 %	-100.17 %	-67.97 %	-72.84 %
DBVT's Total Ranking	# 4177	# 4948	# 4444	# 4530	# 4633
Total Assets (TTM) in million	223	307	234	130	169
Seq. Total Assets Change	-27.26 %	31.3 %	80.23 %	-23.19 %	209.26 %
Seq. Net Income Change	-	-	-	-	-

DBVT's 5 Years Annual ROA >> Back to DBVT Management Effectiveness >> Compare DBVT ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 103
Sector	# 688
Overall	# 4133

Return On Assets Statistics
High	Average	Low
-33.26 %	-66.78 %	-131.29 %
(Dec 31 2023)		(Mar 31 2025)

Financial Statements
Dbv Technologies S A 's Assets	$ 223 million	DBVT's Balance sheet
Dbv Technologies S A 's Income	$ -50 million	Quarterly DBVT's Income Statement
DBVT's Income by Division		See DBVT's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	40.08 %	4.67 %	5.11 %	-4.82 %	-8.87 %
Total Assets in million	537	383	366	348	366
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-147	-114	-73	-96	-98
Annual Return On Assets	-27.37 %	-29.72 %	-19.86 %	-27.64 %	-26.72 %

DBVT's 5 Years Annual ROA >> Back to DBVT Management Effectiveness >> Compare DBVT ROA to its Competitors

More Return On Assets Ratios
DBVT's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DBVT's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DBVT's Competitors
Subscribers only: Roa for Dbv Technologies S A 's Suppliers
Subscribers only: Return On Assets for DBVT's Customers

You may also want to know
DBVT's Roi	DBVT's Inventory Turnover Ratio	DBVT's Growth Rates	DBVT's Dividend Comparisons
	DBVT's Profitability Ratios	DBVT's Asset Turnover Ratio	DBVT's Dividend Growth
DBVT's Roe	DBVT's Valuation Ratios	DBVT's Financial Strength Ratios	DBVT's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-07-18T04:17:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.